Acumen Pharmaceuticals has recently priced its $130 million offering. Which aims to strengthen the company’s financial position and support its…
Browsing: investors
Stocks of COLB, ONDS, and COSM are experiencing a decline in pre-market trading, with COLB showing the most significant decrease,…
The oil market is currently facing significant challenges, with prices experiencing an excessive decline in the physical market. The ongoing…
In the Healthcare Sector, PainReform and T2 Biosystems emerged as top gainers, while Vir and Aspira faced losses in a…
In today’s fast-paced stock market, several companies experienced significant movements, capturing the attention of investors. Among the standout performers were…
Germany-based MorphoSys AG (MOR) recently reported its financial performance for the fourth quarter and full year of the 2020 fiscal…
MorphoSys is making significant strides in its Phase 3 myelofibrosis program, completing it 16% faster than expected [1]. This is…